After scientific review, the British regulatory agency ruled out AstraZeneca’s Covid-19 vaccine as the cause of blood clots, and it is recommended to continue to use it
Mexico City- The British drug regulator supported AstraZeneca’s Covid-19 vaccine on Thursday, saying that after several European countries suspended its use due to reports of such cases, there is no evidence that it causes blood clots.
After a scientific review of all available data, the U.S. Medicines and Health Products Regulatory Agency (MHRA) determined that the benefits of the vaccine outweigh the risks and recommended that the vaccine continue to be used.
MHRA said in a statement: “The existing evidence does not indicate that venous thrombosis (venous thromboembolism) is caused by the Covid-19 AstraZeneca vaccine.”
The agency pointed out that blood clot cases are “isolated reports” and these types of conditions can occur naturally without the need for vaccination. He emphasized that in the UK, only 5 possible blood clots have been reported in 11 million doses of AstraZeneca vaccine.
Major European medical regulators will also make a decision on this topic of investigation on Thursday. The Expert Committee of the European Medicines Agency (EMA) will announce its findings later on Thursday.
Earlier this week, more than a dozen countries including Germany, France, Spain and Italy suspended the vaccine after several cases of the 17 million people who received at least one dose of the vaccine reported abnormal blood clots. Vaccination. in Europe.
Both EMA and the World Health Organization point out that there is currently no evidence that the vaccine has caused such a reaction, and the benefits of immunization far outweigh the potential risks of vaccination. The drugmaker said that after a thorough review of its data, it found no evidence of an increased risk of blood clots in any age group or gender in any country.